Transformation of myelodysplastic syndrome (MDS) to hypocellular Acute Myeloid Leukemia (AML) post renal transplant.

被引：0
|
作者：
Hasni, K
Gunnala, V
Shah, M
Hoang, T
Kung, SC
Brodsky, I
Kumar, MA
Heifets, M
机构：
[1] Drexel Univ, Coll Med, Div Nephrol, Philadelphia, PA 19104 USA
[2] Drexel Univ, Coll Med, Div Heatol Oncol, Philadelphia, PA 19104 USA
[3] Drexel Univ, Coll Med, Div Transplant, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：923A / 923A
页数：1
相关论文
共 50 条
  • [1] Erythropoietin (EPO)-dependent transformation of myelodysplastic syndrome (MDS) to acute myeloid leukemia (AML).
    Bunworasate, U
    Arnouk, H
    Minderman, H
    O'Loughlin, KL
    Sait, SNJ
    Barcos, M
    Baer, MR
    BLOOD, 2000, 96 (11) : 259B - 259B
  • [2] Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients
    Rollison, Dana E.
    Shain, Kenneth H.
    Lee, Ji-Hyun
    Hampras, Shalaka S.
    Fulp, William
    Fisher, Kate
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey
    Xu, Qiang
    Knight, Robert D.
    List, Alan F.
    Dalton, William
    Komrokji, Rami
    BLOOD, 2014, 124 (21)
  • [3] Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report
    Song, Kui
    Xu, Xiaojun
    Li, Min
    ONCOLOGY LETTERS, 2015, 10 (01) : 422 - 424
  • [4] Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ault, Patricia S.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Faderl, Stefan H.
    Jabbour, Elias J.
    Cleeland, Charles S.
    Cortes, Jorge E.
    BLOOD, 2013, 122 (21)
  • [5] Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in Down syndrome: Pathologic aspects
    Mast, K.
    Taub, J. W.
    Alonzo, T.
    Mosse, C.
    Gamis, A. S.
    Mathew, P.
    Jones, H.
    Hitzler, J.
    Head, D. R.
    LEUKEMIA RESEARCH, 2013, 37 : S89 - S90
  • [6] Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ahaneku, Hycienth
    Cortes, Jorge E.
    Manero, Guillermo Garcia
    Kantarjian, Hagop M.
    Shi, Qiuling
    Lin, Huei-Kai
    Limaye, Achala R.
    Cleeland, Charles S.
    BLOOD, 2014, 124 (21)
  • [7] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Germing, Ulrich
    Haferlach, Torsten
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
  • [8] The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?
    Snow, Anson
    Zeidner, Joshua F.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [9] Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) following treatment for ovarian cancer
    Gupta, B.
    Sait, S. N.
    Block, A. W.
    Ford, L. A.
    Moysich, K. B.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
    Steensma, D.
    Abedi, M.
    Bejar, R.
    Cogle, C.
    Foucar, K.
    Garcia-Manero, G.
    George, T.
    Grinblatt, D.
    Komrokji, R.
    Maciejewski, J.
    Pollyea, D.
    Roboz, G.
    Savona, M.
    Scott, B.
    Sekeres, M.
    Thompson, M.
    Sugrue, M.
    Swern, A.
    Nifenecker, M.
    Erba, H.
    LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
12345